1
|
Lipton LR: Familial colorectal cancer and
polyposis genes, pathways and predictions (unpublished PhD thesis).
University of London. 2006.
|
2
|
Kahouli I, Tomaro-Duchesneau C and Prakash
S: Probiotics in colorectal cancer (CRC) with emphasis on
mechanisms of action and current perspectives. J Med Microbiol.
62:1107–1123. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chua YJ and Zalcberg JR: Progress and
challenges in the adjuvant treatment of stage II and III colon
cancers. Expert Rev Anticancer Ther. 8:595–604. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Hamilton SR and Aaltonen LA: Pathology and
genetics. Tumours of the digestive system. WHO Classification of
Tumours. 2:IARC Press. (Lyon). 103–119. 2000.
|
7
|
Wei W, Yang Y, Cai J, Cui K, Li RX, Wang
H, Shang X and Wei D: miR-30a-5p suppresses tumor metastasis of
human colorectal cancer by targeting ITGB3. Cell Physiol Biochem.
39:1165–1176. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Singh SR and Rameshwar P: MicroRNA in
development and in the progression of cancer. Springer. (New York,
NY). 2014. View Article : Google Scholar
|
10
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang L, Tang H, Thayanithy V, Subramanian
S, Oberg AL, Cunningham JM, Cerhan JR, Steer CJ and Thibodeau SN:
Gene networks and microRNAs implicated in aggressive prostate
cancer. Cancer Res. 69:9490–9497. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhao D, Sui Y and Zheng X: MiR-331-3p
inhibits proliferation and promotes apoptosis by targeting HER2
through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
Oncol Rep. 35:1075–1082. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zanette DL, Rivadavia F, Molfetta GA,
Barbuzano FG, Proto-Siqueira R, Silva WA Jr, Falcão RP and Zago MA:
miRNA expression profiles in chronic lymphocytic and acute
lymphocytic leukemia. Braz J Med Biol Res. 40:1435–1440. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Nymark P, Guled M, Borze I, Faisal A,
Lahti L, Salmenkivi K, Kettunen E, Anttila S and Knuutila S:
Integrative analysis of microRNA, mRNA and aCGH data reveals
asbestos- and histology-related changes in lung cancer. Genes
Chromosomes Cancer. 50:585–597. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Epis MR, Giles KM, Candy PA, Webster RJ
and Leedman PJ: miR-331-3p regulates expression of neuropilin-2 in
glioblastoma. J Neurooncol. 116:67–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Guo X, Guo L, Ji J, Zhang J, Zhang J, Chen
X, Cai Q, Li J, Gu Q, Liu B, et al: miRNA-331-3p directly targets
E2F1 and induces growth arrest in human gastric cancer. Biochem
Biophys Res Commun. 398:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Epis MR, Giles KM, Kalinowski FC, Barker
A, Cohen RJ and Leedman PJ: Regulation of expression of
deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the
activation of eIF5A, by miR-331-3p and miR-642-5p in prostate
cancer cells. J Biol Chem. 287:35251–35259. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Li X, Zhu J, Liu Y, Duan C, Chang R and
Zhang C: MicroRNA-331-3p inhibits epithelial-mesenchymal transition
by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in
non-small-cell lung cancer. Cancer Sci. 110:1883–1896.
2019.PubMed/NCBI
|
20
|
Chen X, Luo H, Li X, Tian X, Peng B, Liu
S, Zhan T, Wan Y, Chen W, Li Y, et al: miR-331-3p functions as an
oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis.
39:1006–1015. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ebbesen KK, Kjems J and Hansen TB:
Circular RNAs: Identification, biogenesis and function. Biochim
Biophys Acta. 1859:163–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong
F, Ren D, Ye X, Li C, Wang Y, et al: Circular RNAs function as
ceRNAs to regulate and control human cancer progression. Mol
Cancer. 17:792018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Ge J, Jin Y, Lv X, Liao Q, Luo C, Ye G and
Zhang X: Expression profiles of circular RNAs in human colorectal
cancer based on RNA deep sequencing. J Clin Lab Anal.
33:e229522019. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhao ZJ and Shen J: Circular RNA
participates in the carcinogenesis and the malignant behavior of
cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhang L, Song X, Chen X, Wang Q, Zheng X,
Wu C and Jiang J: Circular RNA CircCACTIN promotes gastric cancer
progression by sponging MiR-331-3p and regulating TGFBR1
expression. Int J Biol Sci. 15:1091–1103. 2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Chen HH, Zong J and Wang SJ: LncRNA
GAPLINC promotes the growth and metastasis of glioblastoma by
sponging miR-331-3p. Eur Rev Med Pharmacol Sci. 23:262–270.
2019.PubMed/NCBI
|
28
|
Luan X and Wang Y: LncRNA XLOC_006390
facilitates cervical cancer tumorigenesis and metastasis as a ceRNA
against miR-331-3p and miR-338-3p. J Gynecol Oncol. 29:e952018.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Liu T, Song Z and Gai Y: Circular RNA
circ_0001649 acts as a prognostic biomarker and inhibits NSCLC
progression via sponging miR-331-3p and miR-338-5p. Biochem Biophys
Res Commun. 503:1503–1509. 2018. View Article : Google Scholar : PubMed/NCBI
|
30
|
Xiao B, Kuang Z, Zhang W, Hang J, Chen L,
Lei T, He Y, Deng C, Li W, Lu J, et al: Glutamate ionotropic
receptor kainate type subunit 3 (GRIK3) promotes
epithelial-mesenchymal transition in breast cancer cells by
regulating SPDEF/CDH1 signaling. Mol Carcinog. 58:1314–1323.
2019.PubMed/NCBI
|
31
|
Gong B, Li Y, Cheng Z, Wang P, Luo L,
Huang H, Duan S and Liu F: GRIK3: A novel oncogenic protein related
to tumor TNM stage, lymph node metastasis, and poor prognosis of
GC. Tumour Biol. 39:10104283177043642017. View Article : Google Scholar : PubMed/NCBI
|
32
|
Novák J and Fabian P: Comments on the TNM
classification of malignant tumours-7th edition. Klin Onkol.
24:149–150. 2011.(In Czech). PubMed/NCBI
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Li GF, Li L, Yao ZQ and Zhuang SJ:
Hsa_circ_0007534/miR-761/ZIC5 regulatory loop modulates the
proliferation and migration of glioma cells. Biochem Biophys Res
Commun. 499:765–771. 2018. View Article : Google Scholar : PubMed/NCBI
|
35
|
Yin Q, Wang PP, Peng R and Zhou H: MiR-19a
enhances cell proliferation, migration, and invasiveness through
enhancing lymphangiogenesis by targeting thrombospondin-1 in
colorectal cancer. Biochem Cell Biol. 97:731–739. 2019. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zhang H, Wang R and Wang M: miR-331-3p
suppresses cell invasion and migration in colorectal carcinoma by
directly targeting NRP2. Oncol Lett. 18:6501–6508. 2019.PubMed/NCBI
|
37
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Zhang M, Song Y and Zhai F: ARFHPV E7
oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a
negative feedback loop to regulate the apoptosis in the
tumorigenesis in HPV positive cervical cancer. J Cell Biochem.
119:4397–4407. 2018. View Article : Google Scholar : PubMed/NCBI
|
39
|
Jiang W, Zhang X, Chu Q, Lu S, Zhou L, Lu
X, Liu C, Mao L, Ye C, Timko MP, et al: The circular RNA profiles
of colorectal tumor metastatic cells. Front Genet. 9:342018.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Huang WJ, Wang Y, Liu S, Yang J, Guo SX,
Wang L, Wang H and Fan YF: Silencing circular RNA hsa_circ_0000977
suppresses pancreatic ductal adenocarcinoma progression by
stimulating miR-874-3p and inhibiting PLK1 expression. Cancer Lett.
422:70–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
41
|
Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S
and Yuan H: Microarray profile of circular RNAs identifies
hsa_circ_0014130 as a new circular RNA biomarker in non-small cell
lung cancer. Sci Rep. 8:28782018. View Article : Google Scholar : PubMed/NCBI
|
42
|
Li G, Yang H, Han K, Zhu D, Lun P and Zhao
Y: A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis
by increasing the expression of miR-142-3p target ITGB8 in glioma.
Biochem Biophys Res Commun. 498:254–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
43
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
44
|
Yuan Y, Xiang W, Yanhui L, Ruofei L, Yunhe
M, Jiewen L and Qing M: Dysregulation of microRNA-128 expression in
WHO grades 2 glioma is associated with glioma-associated epilepsy:
Down-regulation of miR-128 induces glioma-associated seizure.
Epilepsy Res. 127:6–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
45
|
Pradhan MP, Desai A and Palakal MJ:
Systems biology approach to stage-wise characterization of
epigenetic genes in lung adenocarcinoma. BMC Syst Biol. 7:1412013.
View Article : Google Scholar : PubMed/NCBI
|